Review: The Emerging Role of Metformin as Aromatase Inhibitor in Breast Cancer

UMI Medical Journal

View Publication Info
 
 
Field Value
 
Title Review: The Emerging Role of Metformin as Aromatase Inhibitor in Breast Cancer
 
Creator Badawi, Amrilmaen
 
Description The prevalence of breast cancer is still very high among women, in particular post-menopausal women. There are many factors contributed to the diseases, including diabetes. Recently, it has been emerged that metformin, an antidiabetic agent, is capable of reducing the risk of developing breast cancer among post-menopausal women, and act as aromatase inhibitors (AIs) which inhibits the production of estrogen. In this review, we focus in discussing the possible work mechanism of metformin as AIs and what is in the pipeline on clinical trials.
 
Publisher Fakultas Kedokteran Universitas Muslim Indonesia
 
Date 2019-12-31
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
 
Format application/pdf
 
Identifier http://jurnal.fk.umi.ac.id/index.php/umimedicaljournal/article/view/63
10.33096/umj.v4i2.63
 
Source UMI Medical Journal; Vol 4 No 2 (2019): December 2019; 1-10
UMI Medical Journal; Vol 4 No 2 (2019): December 2019; 1-10
2685-7561
2548-4079
 
Language eng
 
Relation http://jurnal.fk.umi.ac.id/index.php/umimedicaljournal/article/view/63/63
 
Rights Copyright (c) 2019 UMI Medical Journal
 

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us

Twitter

Copyright © 2015-2018 Simon Fraser University Library